CONMED CorpCNMD
Market cap
$1.3B
P/E ratio
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Cash and cash equivalents | - | - | - | - | - | - | - | - | - | 27 | 21 | 29 | 24 | 24 |
| Accounts Receivable, after Allowance for Credit Loss, Current | 136 | 139 | 140 | 129 | 134 | 148 | 167 | 182 | 189 | 177 | 184 | 191 | 242 | 238 |
| Inventories | 168 | 156 | 143 | 148 | 167 | 136 | 141 | 155 | 165 | 195 | 232 | 332 | 318 | 347 |
| Prepaid expenses and other current assets | 16 | 15 | 17 | 22 | 15 | 19 | 16 | 21 | 18 | 17 | 24 | 29 | 31 | 31 |
| Total current assets | 357 | 346 | 372 | 381 | 407 | 331 | 357 | 374 | 397 | 417 | 460 | 581 | 616 | 640 |
| Property, plant and equipment, net | 139 | 139 | 139 | 133 | 125 | 122 | 116 | 113 | 119 | 111 | 109 | 116 | 121 | 116 |
| Deferred income taxes | - | - | - | - | - | - | - | 5 | 6 | 7 | 10 | 10 | 11 | 11 |
| Goodwill | 235 | 257 | 248 | 256 | 261 | 398 | 402 | 400 | 618 | 618 | 618 | 815 | 807 | 805 |
| Other intangible assets, net | 196 | 191 | 319 | 316 | 308 | 420 | 415 | 413 | 533 | 502 | 471 | 682 | 649 | 618 |
| Other assets | - | - | - | - | - | - | - | - | - | - | - | 94 | 96 | 116 |
| Total assets | 936 | 1,084 | 1,091 | 1,098 | 1,113 | 1,329 | 1,358 | 1,369 | 1,775 | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |
| Current portion of long-term debt | - | - | - | - | - | - | - | - | 14 | 18 | 12 | 70 | 1 | 1 |
| Accounts payable | 21 | 24 | 27 | 24 | 35 | 42 | 42 | 53 | 56 | 53 | 58 | 73 | 88 | 102 |
| Accrued compensation and benefits | 31 | 34 | 33 | 36 | 32 | 32 | 34 | 43 | 54 | 50 | 60 | 55 | 70 | 65 |
| Other current liabilities | 18 | 64 | 47 | 52 | 49 | 30 | 59 | 46 | 65 | 68 | 66 | 99 | 152 | 110 |
| Total current liabilities | 131 | 123 | 111 | 116 | 120 | 114 | 150 | 161 | 188 | 190 | 197 | 297 | 311 | 278 |
| Long-term debt | - | - | - | - | - | - | - | - | 755 | 735 | 672 | 985 | 973 | 905 |
| Deferred income taxes | - | - | - | - | - | - | - | - | - | 58 | 69 | 67 | 61 | 74 |
| Other long-term liabilities | 50 | 87 | 45 | 49 | 24 | 27 | 27 | 26 | 47 | 59 | 43 | 204 | 121 | 86 |
| Total liabilities | 363 | 477 | 484 | 517 | 528 | 748 | 727 | 707 | 1,065 | 1,043 | 981 | 1,552 | 1,466 | 1,344 |
| Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Paid-in capital | 322 | 324 | 326 | 320 | 325 | 329 | 334 | 342 | 379 | 383 | 397 | 413 | 447 | 477 |
| Retained earnings | 354 | 378 | 396 | 406 | 415 | 407 | 440 | 465 | 471 | 457 | 497 | 413 | 453 | 560 |
| Accumulated other comprehensive loss | -26 | -28 | -18 | -40 | -54 | -59 | -49 | -56 | -59 | -64 | -54 | -58 | -50 | -59 |
| Less: Treasury stock, at cost; 397,860 and 534,000 shares in 2024 and 2023, respectively | 77 | 68 | 99 | 105 | 101 | 97 | 94 | 89 | 81 | 68 | 54 | 23 | 15 | 16 |
| Total shareholders' equity | 573 | 607 | 606 | 581 | 585 | 581 | 631 | 662 | 710 | 709 | 785 | 746 | 834 | 963 |
| Total liabilities and shareholders' equity | 936 | 1,084 | 1,091 | 1,098 | 1,113 | 1,329 | 1,358 | 1,369 | 1,775 | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |